Similar Efficacy and Safety of Basaglar(®) and Lantus(®) in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study...

Por Pollom, Robyn K., Costigan, Timothy, Lacaya, Lyndon B., Ilag, Liza L., Hollander, Priscilla A.
Publicado no Diabetes Ther (2018)

Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus(®) Insulin Glargine

Por Ilag, Liza L., Costigan, Timothy M., Deeg, Mark A., Pollom, Robyn K., Chang, Curtis L., Konrad, Robert J., Prince, Melvin J.
Publicado no Diabetes Ther (2017)

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

Por Polonsky, William H., Arsenault, Joyce, Fisher, Lawrence, Kushner, Pamela, Miller, Eden M., Pearson, Teresa L., Tracz, Mariusz, Harris, Stewart, Hermanns, Norbert, Scholz, Bernd‐M., Pollom, Robyn K., Perez‐Nieves, Magaly, Pollom, Roy Daniel, Hadjiyianni, Irene
Publicado no Int J Clin Pract (2017)